
October 30, 2025
Key Year-over-Year Highlights:
- Gross Margin Expansion: Increased to 88%, up from 71%, representing a 17-point improvement.
- Operating Loss Reduced by 65%: Narrowed to $439,000, from $1.25 million in 2024.
- Net Loss Reduced by 63%: Improved to $482,000, compared to $1.31 million last year.
- Deferred Revenue Growth: Rose 186% to $582,000, from $203,000 in 2024, reflecting secured multi-year customer contracts and strong adoption of the Map D platform.
- Total Assets Up +92%: Grew to $2.17 million, from $1.13 million a year earlier.
Margin Expansion, and Operational Improvements Ahead of Eventdex Acquisition
Nextech3D.ai (CSE:NTAR)(OTCQB:NEXCF)(FSE:1SS), an AI-first technology company specializing in AI event management through its flagship Map D and Eventdex platforms, 3D modeling, and spatial computing, is pleased to announce its financial results for the quarter ended September 30, 2025.
20% Sequential Quarter-over-Quarter Growth Marks a New Growth Curve Driven by The company's AI Event Suite (Q2 vs. Q1 2025)
Nextech3D.ai delivered solid quarter-over-quarter sequential performance, underscoring the continued strength of its high-margin event technology business.
- Revenue increased 20% sequentially, rising to $390,755 in Q2 2025, up from $325,000 in Q1 2025 marking the beginning of a new growth curve.
- Deferred revenue up +186% year over year from $203,000 to $521,000
- Gross margins remained strong at 88%, supported by higher contributions from the Map D platform and continued AI-driven workflow efficiencies.
- The Company maintained disciplined cost controls, driving operational leverage and improved profitability.
Year-over-Year Comparison (Sep 2025 vs. Sep 2024)
While total revenue declined 48% year-over-year from $756,476 in 2024 to $390,755 in 2025, this reduction reflects the planned conclusion of Nextech's Amazon 3D modeling contract in Q4 2024. This strategic transition allowed the Company to fully refocus on its higher-margin AI and event-technology ecosystem, which is now driving sustainable growth and profitability.
Key Year-over-Year Highlights:
- Gross Margin Expansion: Increased to 88%, up from 71%, representing a 17-point improvement.
- Operating Loss Reduced by 65%: Narrowed to $439,000, from $1.25 million in 2024.
- Net Loss Reduced by 63%: Improved to $482,000, compared to $1.31 million last year.
- Deferred Revenue Growth: Rose 186% to $582,000, from $203,000 in 2024, reflecting secured multi-year customer contracts and strong adoption of the Map D platform.
- Total Assets Up +92%: Grew to $2.17 million, from $1.13 million a year earlier.
- Accounts Payable Down 32%: Reduced to $3.0 million, from $4.4 million, demonstrating disciplined cash management and operational efficiency.
Strategic Growth Outlook
The acquisition of Eventdex, which closed in Q3 2025, marks the acceleration of Nextech3D.ai's next growth phase. Eventdex generated approximately $700,000 in revenue in 2024 and brings a strong customer base, complementary product suite, and recurring revenue model.
Together with Map D, the combined companies now serve over 550 customers, creating opportunities to cross-sell products across a unified event technology ecosystem that includes registration, ticketing, mobile apps, floor mapping, AI matchmaking, and blockchain ticketing.
CEO Commentary - Evan Gappelberg, CEO of Nextech3D.ai
"This quarter's results show meaningful progress on all fronts - profitability, margins, and recurring revenue. The conclusion of our Amazon contract in Q4 2024 was a strategic turning point that allowed us to fully commit to our AI-first event technology model. With Eventdex now integrated and demand accelerating, we see a clear path to sustainable growth through 2026 and beyond."
"With improved gross margins to 90%, operating costs cut by more than 60%, we narrowed our net loss by over 70% and believe we have now firmly set the stage for profitability. These results reflect the discipline, focus and hard work of our team as we have streamlined operations and prioritized scalable, high-value product lines and revenue growth."
About Nextech3D.ai
Nextech3D.ai (OTCQX:NEXCF)(CSE:NTAR)(FSE:1SS) is an AI-first technology company developing advanced solutions for event management, 3D modeling, and spatial computing. Through its flagship Map D and Eventdex platforms, Nextech3D.ai powers thousands of events annually with interactive floor mapping, registration, ticketing, mobile apps, AI matchmaking, and now, blockchain ticketing and accreditation.
For further information, please visit: www.Nextech3D.ai.
See full report on SEDAR
Investor Relations: investors@nextechar.com
For more information, visit Nextech3D.ai.
Sign up for Investor News and Info - Click Here
For more information and full report go to
For further information, please contact:
Nextech3D.ai
Evan Gappelberg /CEO and Director
866-ARITIZE (274-8493)
Forward-looking Statements The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. Certain information contained herein may constitute "forward-looking information" under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as, "will be" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements regarding the completion of the transaction are subject to known and unknown risks, uncertainties and other factors. There can be no assurance that such statements will prove to be accurate, as future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Nextech will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.
NTAR:CC

Sign up to get your FREE
Nextech3D.ai Investor Kit
and hear about exciting investment opportunities.
- Corporate info
- Insights
- Growth strategies
- Upcoming projects
GET YOUR FREE INVESTOR KIT
The Conversation (0)
05 November
Nextech3D.ai
Disrupting the global events management industry with AI and blockchain
Disrupting the global events management industry with AI and blockchain Keep Reading...
18h
Nextech3D.ai to Acquire Krafty Labs, Expanding AI Event Solutions for Enterprise Clients
Krafty Labs Generated 2025 Year to date Revenue of $1.1 mill with a 72% gross marginAll-Cash Deal for $600,000Acquiring a Blue Chip customers list; Google, Meta, Oracle etcNextech3D.ai Doubles Customer Base to 1000+Nextech3D.ai is Accelerating its Growth As a One-Stop AI Event Tech Suite NEW... Keep Reading...
02 December
Nextech3D.ai Announces Definitive Agreement to Acquire 100% of ARway, Streamlining Operations
Nextech already owns 15million shares or about 40% of the 38 million shares outstanding in Arway Corporation ("Arway") OTCQB: ARWYF / CSE: ARWY TORONTO, ON / ACCESS Newswire / December 2, 2025 / Nextech3D.ai (CSE:NTAR,OTC:NEXCF)(OTCQX:NEXCF)(FSE:1SS), Nextech an AI-first 3D modeling and event... Keep Reading...
18 November
Nextech3D.ai Accelerates Eventdex Integration; Expands AI Matchmaking and Achieves Milestone Production of 800 Interactive Floor Plans in 2025
TORONTO, ON / ACCESS Newswire / November 18, 2025 / Nextech3D.ai (CSE:NTAR,OTC:NEXCF)(OTCQX:NEXCF)(FSE:1SS), an AI-first 3D modeling and event technology company, today announced major milestones across its unified event-tech platform, including accelerated integration of its newly acquired... Keep Reading...
10 November
Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys
TORONTO, ON / ACCESS Newswire / November 10, 2025 / Nextech3D.ai (CSE:NTAR,OTC:NEXCF)(OTCQX:NEXCF)(FSE:1SS), an AI-first technology company specializing in AI event management through its flagship Map D and Eventdex platforms, 3D modeling, and spatial computing, is pleased to announce that CEO... Keep Reading...
07 November
Nextech3D.ai and Arway Provide Business Combination Update
TORONTO, ON / ACCESS Newswire / November 7, 2025 / Nextech3D.ai (the "Company" or "Nextech") (OTCQX:NEXCF)(CSE:NTAR,OTC:NEXCF)(FSE:EP2) and Arway Corporation ("Arway") (OTCQB:ARWYF) (CSE:ARWY) are pleased to provide an update today at the request of staff of the Ontario Securities Commission in... Keep Reading...
7h
5 Small-cap Biotech ETFs to Watch
Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, they give sector participants exposure to many biotech companies via one vehicle.ETFs are a popular choice as they allow investors to enter the market more safely... Keep Reading...
02 December
Invion Secures Expanded Photosoft Global Exclusive License
Invion Limited (IVX:AU) has announced Invion Secures Expanded Photosoft Global Exclusive LicenseDownload the PDF here. Keep Reading...
01 December
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
Phase II ARCHER trial showed a significant reduction in left ventricular (LV) mass (p=0.0117) and improvements in multiple key cardiac MRI (CMR) measures of structural heart recovery in patients with acute myocarditis.Results provide clinical evidence that CardiolRxâ„¢ reduces inflammation-driven... Keep Reading...
25 November
Transforming Disease Detection with AI-Driven Biological Insights
Artificial intelligence (AI) is fundamentally reshaping biotechnology and healthcare, unlocking the secrets hidden within complex biological data. Machine learning in genomics and proteomics is transforming how diseases are detected, monitored and treated. Central to this revolution are... Keep Reading...
13 November
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040
Once issued, this new U.S. patent covers the use of CardiolRxâ„¢ and CRD-38 for a broad range of cardiac disorders, including atherosclerosis and heart failure, significantly expanding intellectual property protection in the world's largest pharmaceutical market.This allowance fortifies Cardiol's... Keep Reading...
05 November
Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases
The ESC M&PD meeting brings together the world's experts working to improve the treatment of myocarditis and pericarditis.Presentation to provide comprehensive findings from the ARCHER trial following the reporting of topline results demonstrating a notable improvement in extracellular volume... Keep Reading...
Latest News

Sign up to get your FREE
Nextech3D.ai Investor Kit
and hear about exciting investment opportunities.
- Corporate info
- Insights
- Growth strategies
- Upcoming projects
GET YOUR FREE INVESTOR KIT
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00




